EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Expert consensus on quality control indicators for integrative medicine in rheumatoid arthritis (2023 version)

Qingwen Tao, Jinping Wang, Zihan Wang, Yuan Xu, Jianming Wang, Yingze Zhang

Advanced Chinese Medicine · 2024

DOI: 10.1002/acm4.13 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Chinese Medicine, 2024. Verfasst von Qingwen Tao und 5 weiteren Autor:innen. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The rising costs of cancer care and subsequent medical financial hardship for cancer survivors and families are well documented in the United States. Less attention has been paid to employment disruptions and loss of household income after a cancer diagnosis and during treatment, potentially resulting in lasting financial hardship, particularly for working‐age adults not yet age‐eligible for Medicare coverage and their families. In this article, the authors use a composite patient case to illustrate the adverse consequences of cancer diagnosis and treatment for employment, health insurance coverage, household income, and other aspects of financial hardship. They summarize existing research and provide nationally representative estimates of multiple aspects of financial hardship and health insurance coverage, benefit design, and employee benefits, such as paid sick leave, among working‐age adults with a history of cancer and compare them with estimates among working‐age adults without a history of cancer from the most recently available years of the National Health Interview Survey (2019–2021). Then, the authors identify opportunities for addressing employment and health insurance coverage challenges at multiple levels, including federal, state, and local policies; employers; cancer care delivery organizations; and nonprofit organizations. These efforts, when informed by research to identify best practices, can potentially help mitigate the financial hardship associated with cancer.

Zitieren

APA

Tao, Q., Wang, J., Wang, Z., Xu, Y., Wang, J., & Zhang, Y. (2024). Expert consensus on quality control indicators for integrative medicine in rheumatoid arthritis (2023 version). Advanced Chinese Medicine. https://doi.org/10.1002/acm4.13

Vancouver

Tao Q, Wang J, Wang Z, Xu Y, Wang J, Zhang Y. Expert consensus on quality control indicators for integrative medicine in rheumatoid arthritis (2023 version). Advanced Chinese Medicine. 2024. doi:10.1002/acm4.13

BibTeX
@article{Tao2024,
  author = {Tao, Qingwen and Wang, Jinping and Wang, Zihan and Xu, Yuan and Wang, Jianming and Zhang, Yingze},
  title = {Expert consensus on quality control indicators for integrative medicine in rheumatoid arthritis (2023 version)},
  journal = {Advanced Chinese Medicine},
  year = {2024},
  doi = {10.1002/acm4.13}
}
Kostenlos starten →